First trimester human umbilical cord perivascular cells (FTM HUCPVC) modulate the inflammatory response after myocardial infarction (MI) by regulating macrophage polartisation and reducing apoptosis.
A novel combination cell therapy using first trimester human umbilical cord-derived mesenchymal stromal cells and endothelial progenitor cells significantly improves cardiac recovery after myocardial infarction
144 - Low glucose environment triggers significant angiogenic response from first trimester (FTM) but not term human umbilical cord perivascular cells (HUCPVCs)
124 - Cytokine secretion of LPS activated human peripheral lymphocytes can be modulated by First trimester Human Umbilical Cord Perivascular Cells (FTM-HUCPVCs)
105 - First trimester human umbilical cord perivascular cells (FTM HUCPVCs) secrete key angiogenic factors and significantly improve the development of both rat aortic tissue-derived and bone marrow EPC-derived endothelial networks, in a cell type dependent manner
35 - First trimester human umbilical cord perivascular cells (FTM HUCPVCs) expanded with cGMP compliant human platelet outperform conventional and older MSC sources as regenerative therapy in a rat myocardial infarction (MI) model
291 - Blood brain barrier integrity and edema formation after moderate traumatic brain injury is improved with human umbilical cord perivascular cell therapy
240 - Co-administration of first trimester umbilical cord-derived perivascular cells (FTM HUCPVCs) with endothelial progenitor cells (EPCs) leads to enhanced angiogenesis, both in vitro and in vivo, compared to either cell type alone
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies